Cite
Integrin beta3 Leu33Pro homozygosity and risk of cancer.
MLA
Bojesen, Stig E., et al. “Integrin Beta3 Leu33Pro Homozygosity and Risk of Cancer.” JNCI: Journal of the National Cancer Institute, vol. 95, no. 15, Aug. 2003, pp. 1150–57. EBSCOhost, https://doi.org/10.1093/jnci/djg005.
APA
Bojesen, S. E., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2003). Integrin beta3 Leu33Pro homozygosity and risk of cancer. JNCI: Journal of the National Cancer Institute, 95(15), 1150–1157. https://doi.org/10.1093/jnci/djg005
Chicago
Bojesen, Stig E, Anne Tybjaerg-Hansen, and Børge G Nordestgaard. 2003. “Integrin Beta3 Leu33Pro Homozygosity and Risk of Cancer.” JNCI: Journal of the National Cancer Institute 95 (15): 1150–57. doi:10.1093/jnci/djg005.